2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      High Capability of Pentagalloylglucose (PGG) in Inhibiting Multiple Types of Membrane Ionic Currents

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Pentagalloyglucose (PGG, penta- O-galloyl-β- d-glucose; 1,2,3,4,6-pentagalloyl glucose), a pentagallic acid ester of glucose, is recognized to possess anti-bacterial, anti-oxidative and anti-neoplastic activities. However, to what extent PGG or other polyphenolic compounds can perturb the magnitude and/or gating of different types of plasmalemmal ionic currents remains largely uncertain. In pituitary tumor (GH 3) cells, we found out that PGG was effective at suppressing the density of delayed-rectifier K + current ( I K(DR)) concentration-dependently. The addition of PGG could suppress the density of proton-activated Cl current ( I PAC) observed in GH 3 cells. The IC 50 value required for the inhibitory action of PGG on I K(DR) or I PAC observed in GH 3 cells was estimated to be 3.6 or 12.2 μM, respectively, while PGG (10 μM) mildly inhibited the density of the erg-mediated K + current or voltage-gated Na + current. The presence of neither chlorotoxin, hesperetin, kaempferol, morin nor iberiotoxin had any effects on I PAC density, whereas hydroxychloroquine or 4-[(2-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5yl)oxy] butanoic acid suppressed current density effectively. The application of PGG also led to a decrease in the area of voltage-dependent hysteresis of I PAC elicited by long-lasting isosceles-triangular ramp voltage command, suggesting that hysteretic strength was lessened in its presence. In human cardiac myocytes, the exposure to PGG also resulted in a reduction of ramp-induced I K(DR) density. Taken literally, PGG-perturbed adjustment of ionic currents could be direct and appears to be independent of its anti-oxidative property.

          Related collections

          Most cited references50

          • Record: found
          • Abstract: found
          • Article: not found

          Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology

          Despite widespread clinical use of antimalarial drugs such as hydroxychloroquine and chloroquine in the treatment of rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and other inflammatory rheumatic diseases, insights into the mechanism of action of these drugs are still emerging. Hydroxychloroquine and chloroquine are weak bases and have a characteristic 'deep' volume of distribution and a half-life of around 50 days. These drugs interfere with lysosomal activity and autophagy, interact with membrane stability and alter signalling pathways and transcriptional activity, which can result in inhibition of cytokine production and modulation of certain co-stimulatory molecules. These modes of action, together with the drug's chemical properties, might explain the clinical efficacy and well-known adverse effects (such as retinopathy) of these drugs. The unknown dose-response relationships of these drugs and the lack of definitions of the minimum dose needed for clinical efficacy and what doses are toxic pose challenges to clinical practice. Further challenges include patient non-adherence and possible context-dependent variations in blood drug levels. Available mechanistic data give insights into the immunomodulatory potency of hydroxychloroquine and provide the rationale to search for more potent and/or selective inhibitors.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Lysosomal acidification mechanisms.

            J Mindell (2011)
            Lysosomes, the terminal organelles on the endocytic pathway, digest macromolecules and make their components available to the cell as nutrients. Hydrolytic enzymes specific to a wide range of targets reside within the lysosome; these enzymes are activated by the highly acidic pH (between 4.5 and 5.0) in the organelles' interior. Lysosomes generate and maintain their pH gradients by using the activity of a proton-pumping V-type ATPase, which uses metabolic energy in the form of ATP to pump protons into the lysosome lumen. Because this activity separates electric charge and generates a transmembrane voltage, another ion must move to dissipate this voltage for net pumping to occur. This so-called counterion may be either a cation (moving out of the lysosome) or an anion (moving into the lysosome). Recent data support the involvement of ClC-7, a Cl(-)/H(+) antiporter, in this process, although many open questions remain as to this transporter's involvement. Although functional results also point to a cation transporter, its molecular identity remains uncertain. Both the V-ATPase and the counterion transporter are likely to be important players in the mechanisms determining the steady-state pH of the lysosome interior. Exciting new results suggest that lysosomal pH may be dynamically regulated in some cell types.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Hydroxychloroquine in systemic lupus erythematosus (SLE).

              Hydroxychloroquine (HCQ) is an alkalinizing lysosomatropic drug that accumulates in lysosomes where it inhibits some important functions by increasing the pH. HCQ has proved to be effective in a number of autoimmune diseases including systemic lupus erythematosus (SLE). Areas covered: In this review the mechanisms of action, the efficacy, and the safety of HCQ in the management of patients with SLE have been reviewed. HCQ may reduce the risk of flares, allow the reduction of the dosage of steroids, reduce organ damage, and prevent the thrombotic effects of anti-phospholipid antibodies. The drug is generally safe and may be prescribed to pregnant women. However, some cautions are needed to prevent retinopathy, a rare but serious complication of the prolonged use of HCQ. Expert opinion: HCQ may offer several advantages not only in patients with mild SLE but can also exert important beneficial effects in lupus patients with organ involvement and in pregnant women. The drug has a low cost and few side effects. These characteristics should encourage a larger use of HCQ, also in lupus patients with organ involvement.
                Bookmark

                Author and article information

                Journal
                Int J Mol Sci
                Int J Mol Sci
                ijms
                International Journal of Molecular Sciences
                MDPI
                1422-0067
                09 December 2020
                December 2020
                : 21
                : 24
                : 9369
                Affiliations
                [1 ]Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan; cmcvecho2@ 123456gmail.com (W.-T.C.); larry@ 123456mail.ncku.edu.tw (P.-Y.L.)
                [2 ]Division of Cardiovascular Medicine, Chi-Mei Medical Center, Tainan 71004, Taiwan
                [3 ]Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan 71004, Taiwan
                [4 ]Division of Cardiology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 70401, Taiwan
                [5 ]Department of Physiology, National Cheng Kung University Medical College, No. 1, University Road, Tainan 70101, Taiwan
                [6 ]Institute of Basic Medical Sciences, National Cheng Kung University Medical College, Tainan 70101, Taiwan
                [7 ]Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 40402, Taiwan
                Author notes
                [* ]Correspondence: cmcvecho@ 123456mail.ncku.edu.tw ; Tel.: +886-6-2353535-5334; Fax: +886-6-2362780
                Author information
                https://orcid.org/0000-0002-3643-5204
                Article
                ijms-21-09369
                10.3390/ijms21249369
                7763472
                33316951
                0973af92-7c23-49c0-9948-3ef589b398c5
                © 2020 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 17 November 2020
                : 06 December 2020
                Categories
                Article

                Molecular biology
                pentagalloylglucose (penta-o-galloyl-β-d-glucose), delayed-rectifier k+ current,erg-mediated k+ current,proton-activated cl− current,hyperpolarization-activated cation current,voltage-gated na+ current,pituitary cell,heart cell

                Comments

                Comment on this article